UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Emerging therapies in chronic myeloid leukemia

Current cancer drug targets, 2012-06, Vol.12 (5), p.458-470

Gora-Tybor, J

2012

Volltextzugriff (PDF)

Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine

European journal of cancer (1990), 2004-02, Vol.40 (3), p.383-389

2004

Volltextzugriff (PDF)

The Presence of Typical and Atypical BCR-ABL Fusion Genes in Leukocytes of Normal Individuals: Biologic Significance and Implications for the Assessment of Minimal Residual Disease

Blood, 1998-11, Vol.92 (9), p.3362-3367

1998

Volltextzugriff (PDF)

Activity of 2-chlorodeoxyadenosine (cladribine) in 2-hour intravenous infusion in 94 previously treated patients with low grade non-hodgkin's lymphoma

Leukemia & lymphoma, 1997, Vol.26 (1-2), p.99-105

1997

Volltextzugriff (PDF)

Richter syndrome first manifesting as cutaneous B-cell lymphoma clonally distinct from primary B-cell chronic lymphocytic leukaemia

British journal of dermatology (1951), 2005-10, Vol.153 (4), p.833-837

2005

Volltextzugriff (PDF)

Cladribine decreases the level of angiogenic factors in patients with chronic lymphocytic leukemia

Neoplasma, 2002, Vol.49 (3), p.145

2002

Volltextzugriff (PDF)

Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia

Leukemia, 2001-10, Vol.15 (10), p.1510-1516

2001

Volltextzugriff (PDF)

Circulating vascular endothelial growth factor (VEGF) and its soluble receptors in patients with chronic lymphocytic leukemia

European cytokine network (Montrouge), 2005, Vol.16 (1), p.41-46

2005

Volltextzugriff (PDF)

Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia

Mediators of Inflammation, 2003-06, Vol.2003 (3), p.167-171

2003

Volltextzugriff (PDF)

Rituximab Followed by Cladribine in the Treatment of Heavily Pretreated Patients with Indolent Lymphoid Malignancies

Leukemia & lymphoma, 2004-05, Vol.45 (5), p.937-944

2004

Volltextzugriff (PDF)

2-chlorodeoxyadenosine (2-CdA) does not change the expression of Fas antigen on chronic lymphocytic leukaemia cells

Advances in experimental medicine and biology, 2000, Vol.486, p.307

2000

Volltextzugriff (PDF)

Cladribine as monotherapy or combined with dexamethasone and idarubicin or mitoxantrone in previously treated patients with low-grade lymphoid malignancies

Haematologica (Roma), 2000-02, Vol.85 (2), p.215

2000

Volltextzugriff (PDF)

Cladribine combined with mitoxantrone in the treatment of blastic phase of chronic myeloid leukemia

Neoplasma, 2001, Vol.48 (3), p.203

2001

Volltextzugriff (PDF)

Selective induction of leukemia-associated fusion genes by high-dose ionizing radiation

Cancer research (Chicago, Ill.), 1998-02, Vol.58 (3), p.421-425

1998

Volltextzugriff (PDF)

Cladribine in combination with mitoxantrone and cyclophosphamide(CMC) in the treatment of heavily pre-treated patients with advanced indolent lymphoid malignancies

European journal of haematology, 2001-03, Vol.66 (3), p.188-194

2001

Volltextzugriff (PDF)

Combination Regimen of 2-Chlorodeoxyadenosine (Cladribine), Mitoxantrone and Dexamethasone (CMD) in the Treatment of Refractory and Recurrent Low Grade Non-Hodgkin's Lymphoma

Leukemia & lymphoma, 1999, Vol.32 (3-4), p.359-363

1999

Volltextzugriff (PDF)

The effect of subsequent therapies in patients with chronic lymphocytic leukemia previously treated with prednisone and either cladribine or chlorambucil

Haematologica (Roma), 2005-07, Vol.90 (7), p.994

2005

Volltextzugriff (PDF)

The susceptibility of Philadelphia chromosome positive cells to FAS‐mediated apoptosis is not linked to the tyrosine kinase activity of BCR‐ABL

British journal of haematology, 1998-12, Vol.103 (3), p.716-720

1998

Volltextzugriff (PDF)

Comparison of cladribine plus prednisone with chlorambucil plus prednisone in patients with chronic lymphocytic leukemia. Final report of the Polish Adult Leukemia Group (PALG CLL1)

Medical science monitor, 2005-10, Vol.11 (10), p.PI71

2005

Volltextzugriff (PDF)

Effect of platinum(II) choline complex on murine leukemias L1210 and P388

Pharmazie, 1997-07, Vol.52 (7), p.567-569

1997

Volltextzugriff (PDF)

A comparison of the antileukaemic effects of recombinant human tumour necrosis factor-α and its muteins on leukaemia L1210 and leukaemia P388 in mice

Mediators of Inflammation, 1994, Vol.1994 (6), p.411-414

1994

Volltextzugriff (PDF)

The influence of 2- chlorodeoxyadenosine in combination with tumour necrosis factor-α or its mutein on murine leukaemias L1210 and P388

Mediators of Inflammation, 1995, Vol.1995 (3), p.205-208

1995

Volltextzugriff (PDF)

Richter's Syndrome in the Brain First Manifested as an Ischaemic Stroke

Leukemia & lymphoma, 2004-06, Vol.45 (6), p.1261-1267

2004

Volltextzugriff (PDF)

Re-treatment with cladribine-based regimens in relapsed patients with B-cell chronic lymphocytic leukemia: Efficacy and toxicity in comparison with previous treatment

European journal of haematology, 2002-07, Vol.69 (1), p.27-36

2002

Volltextzugriff (PDF)

Coexistence of Chronic Lymphocytic Leukemia and Essential Thrombocythemia

Leukemia & lymphoma, 2003-08, Vol.44 (8), p.1425-1431

2003

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(45)

Sprache

Englisch
(41)
Polnisch
(4)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Emerging therapies in chronic myeloid leukemia

Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine

The Presence of Typical and Atypical BCR-ABL Fusion Genes in Leukocytes of Normal Individuals: Biologic Significance and Implications for the Assessment of Minimal Residual Disease

Activity of 2-chlorodeoxyadenosine (cladribine) in 2-hour intravenous infusion in 94 previously treated patients with low grade non-hodgkin's lymphoma

Richter syndrome first manifesting as cutaneous B-cell lymphoma clonally distinct from primary B-cell chronic lymphocytic leukaemia

Cladribine decreases the level of angiogenic factors in patients with chronic lymphocytic leukemia

Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia

Circulating vascular endothelial growth factor (VEGF) and its soluble receptors in patients with chronic lymphocytic leukemia

Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia

Rituximab Followed by Cladribine in the Treatment of Heavily Pretreated Patients with Indolent Lymphoid Malignancies

2-chlorodeoxyadenosine (2-CdA) does not change the expression of Fas antigen on chronic lymphocytic leukaemia cells

Cladribine as monotherapy or combined with dexamethasone and idarubicin or mitoxantrone in previously treated patients with low-grade lymphoid malignancies

Cladribine combined with mitoxantrone in the treatment of blastic phase of chronic myeloid leukemia

Selective induction of leukemia-associated fusion genes by high-dose ionizing radiation

Cladribine in combination with mitoxantrone and cyclophosphamide(CMC) in the treatment of heavily pre-treated patients with advanced indolent lymphoid malignancies

Combination Regimen of 2-Chlorodeoxyadenosine (Cladribine), Mitoxantrone and Dexamethasone (CMD) in the Treatment of Refractory and Recurrent Low Grade Non-Hodgkin's Lymphoma

The effect of subsequent therapies in patients with chronic lymphocytic leukemia previously treated with prednisone and either cladribine or chlorambucil

The susceptibility of Philadelphia chromosome positive cells to FAS‐mediated apoptosis is not linked to the tyrosine kinase activity of BCR‐ABL

Comparison of cladribine plus prednisone with chlorambucil plus prednisone in patients with chronic lymphocytic leukemia. Final report of the Polish Adult Leukemia Group (PALG CLL1)

Effect of platinum(II) choline complex on murine leukemias L1210 and P388

A comparison of the antileukaemic effects of recombinant human tumour necrosis factor-α and its muteins on leukaemia L1210 and leukaemia P388 in mice

The influence of 2- chlorodeoxyadenosine in combination with tumour necrosis factor-α or its mutein on murine leukaemias L1210 and P388

Richter's Syndrome in the Brain First Manifested as an Ischaemic Stroke

Re-treatment with cladribine-based regimens in relapsed patients with B-cell chronic lymphocytic leukemia: Efficacy and toxicity in comparison with previous treatment

Coexistence of Chronic Lymphocytic Leukemia and Essential Thrombocythemia

Suchergebnisse filtern